PainChek receives funding for 12-month pilot in Welsh care homes

Painchek Ltd (ASX: PCK) announced that Life Sciences Hub Wales had supported it in receiving funding from the Gwent Regional Partnership Board through its Technology Enabled Care Program. The funding will be used to support a 12-months pilot in care environments across Gwent, Wales.

Under Phase 1 of the pilot program, the company will initially encompass 1,000 beds in the residential aged care sector, before Phase 2 sees deployment expanded to hospices, hospitals, and palliative care facilities. Each of these phases is forecasted to have a duration of approx. six months. The pilot is a significant step for the company in Wales as it moves to gain share of a market having approx. 30,000 aged care beds and approx. 20,000 hospital beds. The funding for the pilot will be provided on standard PainChek commercial terms with an indicative license price per bed.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au